LES MEDICAMENTS DOPAMINERGIQUES DANS LE TRAITEMENT DU TREMBLEMENT PARKINSONIEN

Translated title of the contribution: Dopaminergic drugs in the treatment of Parkinsonian tremor

S. Ruggieri, G. Cerone, V. Sconci, A. Agnoli

Research output: Contribution to journalArticle

Abstract

Amongst parkinsonian symptoms tremor is poorly controlled by drug therapy. As a matter of fact, the administration of L-Dopa + DDI shows a partial improvement in tremor. The biochemical mechanism underlying tremor is not yet indentified, but seems to be different from akinesia and rigidity. A neuropharmacological study was performed to investigate the mechanism involved in tremor. An evaluation of the efficacy of dopaminergic drugs and particularly of piribedil is presented. 27 idiopathic hyperkinetic Parkinsonian subjects have been studied. Owing to the fact that precursors (Dopa) are generally able to utilise common enzymatic mechanism (aromatic decarboxylase) receptor agonists and antagonists were used acutely. Tremor was evaluated by a piezoelectric accelerometer and continuously recorded. Among dopaminergic agents, piribedil (0.021 mg/kg) is able to control the parkinsonian tremor. This activity is maximal 10 minutes after administration, decreasing after 30 mins. After 10 mins piribedil was the most active agent among considered.

Original languageFrench
Pages (from-to)247-252
Number of pages6
JournalPsychologie Medicale
Volume11
Issue numberB
Publication statusPublished - 1979

Fingerprint

Dopamine Agents
Tremor
Piribedil
Therapeutics
Dihydroxyphenylalanine
Carboxy-Lyases
Levodopa
Drug Therapy

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Ruggieri, S., Cerone, G., Sconci, V., & Agnoli, A. (1979). LES MEDICAMENTS DOPAMINERGIQUES DANS LE TRAITEMENT DU TREMBLEMENT PARKINSONIEN. Psychologie Medicale, 11(B), 247-252.

LES MEDICAMENTS DOPAMINERGIQUES DANS LE TRAITEMENT DU TREMBLEMENT PARKINSONIEN. / Ruggieri, S.; Cerone, G.; Sconci, V.; Agnoli, A.

In: Psychologie Medicale, Vol. 11, No. B, 1979, p. 247-252.

Research output: Contribution to journalArticle

Ruggieri, S, Cerone, G, Sconci, V & Agnoli, A 1979, 'LES MEDICAMENTS DOPAMINERGIQUES DANS LE TRAITEMENT DU TREMBLEMENT PARKINSONIEN', Psychologie Medicale, vol. 11, no. B, pp. 247-252.
Ruggieri, S. ; Cerone, G. ; Sconci, V. ; Agnoli, A. / LES MEDICAMENTS DOPAMINERGIQUES DANS LE TRAITEMENT DU TREMBLEMENT PARKINSONIEN. In: Psychologie Medicale. 1979 ; Vol. 11, No. B. pp. 247-252.
@article{32280b991ad540128d65c6500f71d4a4,
title = "LES MEDICAMENTS DOPAMINERGIQUES DANS LE TRAITEMENT DU TREMBLEMENT PARKINSONIEN",
abstract = "Amongst parkinsonian symptoms tremor is poorly controlled by drug therapy. As a matter of fact, the administration of L-Dopa + DDI shows a partial improvement in tremor. The biochemical mechanism underlying tremor is not yet indentified, but seems to be different from akinesia and rigidity. A neuropharmacological study was performed to investigate the mechanism involved in tremor. An evaluation of the efficacy of dopaminergic drugs and particularly of piribedil is presented. 27 idiopathic hyperkinetic Parkinsonian subjects have been studied. Owing to the fact that precursors (Dopa) are generally able to utilise common enzymatic mechanism (aromatic decarboxylase) receptor agonists and antagonists were used acutely. Tremor was evaluated by a piezoelectric accelerometer and continuously recorded. Among dopaminergic agents, piribedil (0.021 mg/kg) is able to control the parkinsonian tremor. This activity is maximal 10 minutes after administration, decreasing after 30 mins. After 10 mins piribedil was the most active agent among considered.",
author = "S. Ruggieri and G. Cerone and V. Sconci and A. Agnoli",
year = "1979",
language = "Francese",
volume = "11",
pages = "247--252",
journal = "Psychologie Medicale",
issn = "0048-5756",
number = "B",

}

TY - JOUR

T1 - LES MEDICAMENTS DOPAMINERGIQUES DANS LE TRAITEMENT DU TREMBLEMENT PARKINSONIEN

AU - Ruggieri, S.

AU - Cerone, G.

AU - Sconci, V.

AU - Agnoli, A.

PY - 1979

Y1 - 1979

N2 - Amongst parkinsonian symptoms tremor is poorly controlled by drug therapy. As a matter of fact, the administration of L-Dopa + DDI shows a partial improvement in tremor. The biochemical mechanism underlying tremor is not yet indentified, but seems to be different from akinesia and rigidity. A neuropharmacological study was performed to investigate the mechanism involved in tremor. An evaluation of the efficacy of dopaminergic drugs and particularly of piribedil is presented. 27 idiopathic hyperkinetic Parkinsonian subjects have been studied. Owing to the fact that precursors (Dopa) are generally able to utilise common enzymatic mechanism (aromatic decarboxylase) receptor agonists and antagonists were used acutely. Tremor was evaluated by a piezoelectric accelerometer and continuously recorded. Among dopaminergic agents, piribedil (0.021 mg/kg) is able to control the parkinsonian tremor. This activity is maximal 10 minutes after administration, decreasing after 30 mins. After 10 mins piribedil was the most active agent among considered.

AB - Amongst parkinsonian symptoms tremor is poorly controlled by drug therapy. As a matter of fact, the administration of L-Dopa + DDI shows a partial improvement in tremor. The biochemical mechanism underlying tremor is not yet indentified, but seems to be different from akinesia and rigidity. A neuropharmacological study was performed to investigate the mechanism involved in tremor. An evaluation of the efficacy of dopaminergic drugs and particularly of piribedil is presented. 27 idiopathic hyperkinetic Parkinsonian subjects have been studied. Owing to the fact that precursors (Dopa) are generally able to utilise common enzymatic mechanism (aromatic decarboxylase) receptor agonists and antagonists were used acutely. Tremor was evaluated by a piezoelectric accelerometer and continuously recorded. Among dopaminergic agents, piribedil (0.021 mg/kg) is able to control the parkinsonian tremor. This activity is maximal 10 minutes after administration, decreasing after 30 mins. After 10 mins piribedil was the most active agent among considered.

UR - http://www.scopus.com/inward/record.url?scp=0018741814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018741814&partnerID=8YFLogxK

M3 - Articolo

VL - 11

SP - 247

EP - 252

JO - Psychologie Medicale

JF - Psychologie Medicale

SN - 0048-5756

IS - B

ER -